1[1]Cazaubon C,Gougat J,Bousquet F,et al.Pharmacological characterization of SR 47436,a new nonpeptide AT1 subtype angiotensin Ⅱ receptor antagonisr[J].Pharmaccol Exp Ther,1993,265:826-834.
2[2]Nccciari J,Dcnollc T,Lc CozF,et al.Phatmacokinctics if SR 47436(BMS186295),a mcw angiotensin Ⅱ receptor antagonist in nem(abst)[J].Hypertens,1994,12:88.
3[3]Ribstein J,Sissmann J,Picard A,et al.Effects of the angiotensin Ⅱ antagonist SR 47436(BMS186295) on the prcssor response to exogenous angiotensin Ⅱ and the renin-angiotens in system in sodium replete normal subjects(abst)[J].Hypertens,1994,12:131.
4[4]Hans-Henrik Parving et al.The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetcs[J].N Eng1 Med,2001,345:870-8.September 20,2001.
